Tema ETFs’s Revolution Medicines RVMD Stock Holding History

Tema ETFs’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.9M	Sell	67,959 -3,776	-5%	-$748K	0.52%	52
2026 Q2	$13.4M	Sell	71,735 -26,443	-27%	-$3.86M	0.43%	57
2026 Q1	$9.5M	Sell	98,178 -2,425	-2%	-$245K	0.64%	47
2025 Q4	$8.01M	Sell	100,603 -26,318	-21%	-$1.73M	0.62%	45
2025 Q3	$5.93M	Buy	126,921 +32,694	+35%	+$1.28M	0.49%	59
2025 Q2	$3.47M	Sell	94,227 -351	-0.4%	-$13.5K	0.92%	39
2025 Q1	$3.34M	Buy	94,578 +49,056	+108%	+$1.99M	1%	25
2024 Q4	$1.99M	Buy	+45,522	New	+$2.3M	0.83%	36

Other funds holding RVMD

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

LPPL

Loftus Peak Pty Ltd Sydney, Australia $781M AUM

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Tema ETFs's RVMD Position: Q3 2026 in Review

Tema ETFs reduced its Revolution Medicines (RVMD) stake by 5.3% in Q3 2026, selling an estimated $748K and leaving 67,959 shares worth $13.9M. The position accounts for 0.52% of the portfolio, ranked #52.

Tema ETFs first reported a position in RVMD in Q4 2024 and has held it in 8 quarters since. 86 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Tema ETFs held 67,959 shares of Revolution Medicines worth $13.9M as of Q3 2026.
Tema ETFs sold 3,776 Revolution Medicines shares in Q3 2026, an estimated $748K.
Revolution Medicines made up 0.52% of Tema ETFs's portfolio in Q3 2026, its #52 holding.
Tema ETFs first reported a position in Revolution Medicines in Q4 2024 and has held it in 8 quarters since.
86 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.